The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 01, 2011
Filed:
Apr. 29, 2005
James T. Link, Evanston, IL (US);
Yixian Chen, Park City, IL (US);
Hwan-soo Jae, Glencoe, IL (US);
Jyoti R. Patel, Libertyville, IL (US);
Marina A. Pliushchev, Vernon Hills, IL (US);
Jeffrey J. Rohde, Evanston, IL (US);
Qi Shuai, Gurnee, IL (US);
Bryan K. Sorensen, Antioch, IL (US);
Martin Winn, Deerfield, IL (US);
Dariusz Wodka, Monmouth Junction, NJ (US);
Hong Yong, Libertyville, IL (US);
James T. Link, Evanston, IL (US);
Yixian Chen, Park City, IL (US);
Hwan-Soo Jae, Glencoe, IL (US);
Jyoti R. Patel, Libertyville, IL (US);
Marina A. Pliushchev, Vernon Hills, IL (US);
Jeffrey J. Rohde, Evanston, IL (US);
Qi Shuai, Gurnee, IL (US);
Bryan K. Sorensen, Antioch, IL (US);
Martin Winn, Deerfield, IL (US);
Dariusz Wodka, Monmouth Junction, NJ (US);
Hong Yong, Libertyville, IL (US);
Abbott Laboratories, Abbott Park, IL (US);
Abstract
The present invention relates to compounds which are inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme. The present invention further relates to the use of inhibitors of 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme for the treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, and other diseases and conditions that are mediated by excessive glucocorticoid action.